The Surprising Implications of Familial Association in Disease Risk
Overview
Affiliations
Background: A wide range of diseases show some degree of clustering in families; family history is therefore an important aspect for clinicians when making risk predictions. Familial aggregation is often quantified in terms of a familial relative risk (FRR), and although at first glance this measure may seem simple and intuitive as an average risk prediction, its implications are not straightforward.
Methods: We use two statistical models for the distribution of disease risk in a population: a dichotomous risk model that gives an intuitive understanding of the implication of a given FRR, and a continuous risk model that facilitates a more detailed computation of the inequalities in disease risk. Published estimates of FRRs are used to produce Lorenz curves and Gini indices that quantifies the inequalities in risk for a range of diseases.
Results: We demonstrate that even a moderate familial association in disease risk implies a very large difference in risk between individuals in the population. We give examples of diseases for which this is likely to be true, and we further demonstrate the relationship between the point estimates of FRRs and the distribution of risk in the population.
Conclusions: The variation in risk for several severe diseases may be larger than the variation in income in many countries. The implications of familial risk estimates should be recognized by epidemiologists and clinicians.
The built-in selection bias of hazard ratios formalized using structural causal models.
Post R, van den Heuvel E, Putter H Lifetime Data Anal. 2024; 30(2):404-438.
PMID: 38358572 PMC: 11300553. DOI: 10.1007/s10985-024-09617-y.
Heterogeneity in coronary heart disease risk.
Simonetto C, Rospleszcz S, Kaiser J, Furukawa K Sci Rep. 2022; 12(1):10131.
PMID: 35710917 PMC: 9203574. DOI: 10.1038/s41598-022-14013-3.
Expression of miR-451a in Prostate Cancer and Its Effect on Prognosis.
Fan B, Jin X, Ding Q, Cao C, Shi Y, Zhu H Iran J Public Health. 2021; 50(4):772-779.
PMID: 34183927 PMC: 8219609. DOI: 10.18502/ijph.v50i4.6002.
Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk.
Sud A, Chattopadhyay S, Thomsen H, Sundquist K, Sundquist J, Houlston R Blood. 2019; 134(12):960-969.
PMID: 31395603 PMC: 6789511. DOI: 10.1182/blood.2019001362.
Sud A, Chattopadhyay S, Thomsen H, Sundquist K, Sundquist J, Houlston R Blood. 2018; 132(9):973-976.
PMID: 29991558 PMC: 6194341. DOI: 10.1182/blood-2018-06-858597.